SCHEMBL7962238

SCHEMBL7962238

NC(=O)c1c(C(F)(F)F)c(-c2cccnc2)n2c1C(O)CCC2

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 1/20 0.41
TDP1 Q9NUW8 1/20 0.37
MKNK1 Q9BUB5 3/20 0.36
MKNK2 Q9HBH9 3/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KCNH2 Q12809 1/20 0.36
ATM Q13315 1/20 0.36
P2RX7 Q99572 2/20 0.36
CSNK1D P48730 1/20 0.36
CSNK1E P49674 1/20 0.36
CYP2C9 P11712 1/20 0.35
SLC9A1 P19634 1/20 0.35
ABL1 P00519 3/20 0.35
HTT P42858 1/20 0.35
PDK2 Q15119 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7964875 0.90 CYP11B2 (0.37) CYP11B2TDP1ALDH1A1LMNAL3MBTL1
SCHEMBL7963509 0.87 CFTR (0.40) CYP11B2TDP1ALDH1A1CYP2C9ABL1
SCHEMBL7964582 0.84 CYP11B2 (0.43) CYP11B2MKNK1MKNK2ALDH1A1KCNH2
SCHEMBL2158122 0.84 CYP11B2 (0.43) CYP11B2MKNK1MKNK2ALDH1A1KCNH2
SCHEMBL7964580 0.84 CYP11B2 (0.43) CYP11B2MKNK1MKNK2ALDH1A1KCNH2
SCHEMBL7964715 0.84 CYP11B2 (0.43) CYP11B2TDP1MKNK1MKNK2ALDH1A1
SCHEMBL7963297 0.82 MKNK1 (0.42) CYP11B2MKNK1MKNK2ALDH1A1CSNK1D
SCHEMBL7961681 0.81 CYP11B2 (0.37) CYP11B2TDP1ALDH1A1P2RX7
SCHEMBL7962948 0.81 PLAU (0.35) MKNK1MKNK2LMNAABL1PDK2
SCHEMBL7955168 0.80 CSNK1D (0.39) CYP11B2MKNK1MKNK2P2RX7CSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207675-B1 FOR PROPHYLAXIS AND THERAPY OF DISEASES IN WHICH ARE INVOLVED VIRUSES OF THE HERPES FAMILY AND/OR CYTOKINES IN PARTICULAR TUMOR NERCOSIS FACTOR-ALPHA RHONE-POULENC RORER S.A. (FR) 2001-03-27 US claimed
EP-0946555-A1 PYRROLE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Aventis Pharma S.A. (FR) 1999-10-06 EP claimed
WO-1998025925-A1 PYRROLE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1998-06-18 WO claimed
US-6207675-B1 FOR PROPHYLAXIS AND THERAPY OF DISEASES IN WHICH ARE INVOLVED VIRUSES OF THE HERPES FAMILY AND/OR CYTOKINES IN PARTICULAR TUMOR NERCOSIS FACTOR-ALPHA RHONE-POULENC RORER S.A. (FR) 2001-03-27 US disclosed